NASDAQ: AVIR
Atea Pharmaceuticals Inc Stock Ownership - Who owns Atea Pharmaceuticals?

Insider buying vs selling

Have Atea Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Polly A. MurphyDirector2026-05-186,100$4.17
$25.44kBuy
Andrea CorcoranChief Financial Officer Executive Vice President Legal and Secretary2026-03-1160,000$1.24
$74.40kBuy
Jeanpierre SommadossiPresident CEO and Chairman2026-02-03300,000$1.24
$372.00kBuy
Maria Arantxa HorgaChief Medical Officer2026-01-3116,073$4.24
$68.15kSell
Jeanpierre SommadossiPresident CEO and Chairman2026-01-31106,093$4.24
$449.83kSell
Andrea CorcoranChief Financial Officer Executive Vice President Legal and Secretary2026-01-3116,104$4.24
$68.28kSell
John VavrickaChief Commercial Officer2026-01-3111,570$4.24
$49.06kSell
Wayne FosterEVP Chief Accounting Officer2026-01-3112,132$4.24
$51.44kSell
Janet Mj HammondChief Development Officer2026-01-3114,136$4.24
$59.94kSell

1 of 1

AVIR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVIR insiders and whales buy or sell their stock.

AVIR Shareholders

What type of owners hold Atea Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jeanpierre Sommadossi8.27%6,633,855$34.30MInsider
Cormorant Asset Management LP7.99%6,411,355$33.15MInsider
Andrew A. F. Hack7.00%5,615,659$29.03MInsider
Chung K. Chu1.47%1,176,862$6.08MInsider
Andrea Corcoran1.03%823,576$4.26MInsider
Curated Wealth Partners LLC0.87%695,000$3.59MInstitution
Franklin M. Berger0.67%536,097$2.77MInsider
Rock Springs Capital Management LP0.36%289,695$1.50MInsider
John Vavricka0.21%165,102$853.58kInsider
Bruno Lucidi0.18%142,350$735.95kInsider

1 of 3

AVIR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVIR0.07%28.16%Net Buying
RLMD0.09%3.69%Net BuyingNet Buying
KYTX0.06%42.88%Net Buying
YDES0.00%80.49%Net BuyingNet Buying
SPRY0.09%99.91%Net Selling

Atea Pharmaceuticals Stock Ownership FAQ

Who owns Atea Pharmaceuticals?

Atea Pharmaceuticals (NASDAQ: AVIR) is owned by 0.07% institutional shareholders, 28.16% Atea Pharmaceuticals insiders, and 71.77% retail investors. Jeanpierre Sommadossi is the largest individual Atea Pharmaceuticals shareholder, owning 6.63M shares representing 8.27% of the company. Jeanpierre Sommadossi's Atea Pharmaceuticals shares are currently valued at $34.30M.

If you're new to stock investing, here's how to buy Atea Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.